Limited-sampling strategy for the prediction of boosted hard-gel saquinavir exposure at a dosage of 1000/100 mg twice daily in human immunodeficiency virus-infected individuals.

Source:http://linkedlifedata.com/resource/pubmed/id/17529895

Download in:

View as

General Info

PMID
17529895